Of note, MUC1 CAR-T exhibited antitumor potential against breast cancer (139, 140). At present, a basket trial of MUC1 CAR-T is underway in several malignancies including HCC (NCT02587689). This evidence concerns the gene MUC1 and hepatocellular carcinoma.